Furthermore, TACE can act on the tumor microenvironment by decreasing the percentage of T-Reg and increasing the ratio of CD4+/CD8+, suggesting that TACE may interact with the antitumor activity of ICI (150). This evidence concerns the gene CD4 and neoplasm.